Andrew K. Conner

Andrew K. Conner

Auto-generated profile, based on publicly available information

Andrew K. Conner

Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2020 in Epilepsia
Verified
Journal Article
Closed access
PDF file
ACArpan R. Chakraborty
Arpan R. Chakraborty
NANyle C. Almeida
Nyle C. Almeida
KPKiana Y. Prather
Kiana Y. Prather
COChristen M. O’nEal
Christen M. O’nEal
AWAllison A. Wells
Allison A. Wells
ACAndrew K. Conner
Andrew K. Conner

12 August 2021 in Frontiers in Neurology
Verified
Journal Article
Open access
COChristen M. O'NEal
Christen M. O'NEal
LSLindsey N. Schroeder
Lindsey N. Schroeder
AWAllison A. Wells
Allison A. Wells
SCSixia Chen
Sixia Chen
TSTressie M. Stephens
Tressie M. Stephens
ACAndrew K. Conner
Andrew K. Conner
Background: There are few treatments with limited efficacy for patients with disorders of consciousness (DoC), such as minimally conscious and persistent vegetative state (MCS and PVS).Objective: In this meta-analysis of individual patient data (IPD), we examine studies utilizing transcranial magnetic stimulation (TMS) as a treatment in DoC to determine patient and protocol-specific factors associated with improved outcomes.Methods: We conducted a systematic review of PubMed, Ovid Medline, and Clinicaltrials.gov through April 2020 using the following terms: “minimally conscious state,” or “persistent vegetative state,” or “unresponsive wakefulness syndrome,” or “disorders of consciousness” and “transcranial magnetic stimulation.” Studies utilizing TMS as an intervention and reporting individual pre- and post-TMS Coma Recovery Scale-Revised (CRS-R) scores and subscores were included. Studies utilizing diagnostic TMS were excluded. We performed a meta-analysis at two time points to generate a pooled estimate for absolute change in CRS-R Index, and performed a second meta-analysis to determine the treatment effect of TMS using data from sham-controlled crossover studies. A linear regression model was also created using significant predictors of absolute CRS-R index change.Results: The search yielded 118 papers, of which 10 papers with 90 patients were included. Patients demonstrated a mean pooled absolute change in CRS-R Index of 2.74 (95% CI, 0.62–4.85) after one session of TMS and 5.88 (95% CI, 3.68–8.07) at last post-TMS CRS-R assessment. The standardized mean difference between real rTMS and sham was 2.82 (95% CI, −1.50 to 7.14), favoring rTMS. The linear regression model showed that patients had significantly greater CRS-R index changes if they were in MCS, had an etiology of stroke or intracranial hemorrhage, received 10 or more sessions of TMS, or if TMS was initiated within 3 months from injury.Conclusions: TMS may improve outcomes in MCS and PVS. Further evaluation with randomized, clinical trials is necessary to determine its efficacy in this patient population.

29 September 2015 in Journal of Clinical Neuroscience
Verified
Journal Article
Closed access
PDF file
BBBryan E. Buster
Bryan E. Buster
PBPhillip A. Bonney
Phillip A. Bonney
ACAhmed A. Cheema
Ahmed A. Cheema
CGChad A. Glenn
Chad A. Glenn
ACAndrew K. Conner
Andrew K. Conner
TMTimothy B. Mapstone
Timothy B. Mapstone


1 October 2019 in World Neurosurgery
Verified
Journal Article
Closed access
KOKyle P. O'COnnor
Kyle P. O'COnnor
OAOzer Algan
Ozer Algan
SVSara K. Vesely
Sara K. Vesely
APAli H. Palejwala
Ali H. Palejwala
RBRobert Briggs
Robert Briggs
CGChad A. Glenn
Chad A. Glenn

6 October 2016 in Journal of Neurological Surgery Reports
Verified
Journal Article
Open access
PDF file
BLBrian F. Lich
Brian F. Lich
JBJoshua D. Burks
Joshua D. Burks
CGChad A. Glenn
Chad A. Glenn
MSMichael E. Sughrue
Michael E. Sughrue
ACAndrew K. Conner
Andrew K. Conner
Background The use of intrathecal antibiotic therapy for the treatment of ventriculitis and/or meningitis has demonstrated efficacy especially when sterilization of the cerebrospinal fluid is not possible with intravenous antibiotics alone. Case Description We describe the successful treatment of Enterococcus faecalis ventriculitis utilizing intrathecal linezolid in a 32-year-old female patient with severe allergy to vancomycin, prohibitive bacterial susceptibilities, and failure of previous attempts to sterilize the cerebrospinal fluid despite multimodal treatment. Conclusion Intrathecal linezolid is a useful treatment in the setting of multidrug-resistant bacterial ventriculitis. We present a useful dosing regimen for the administration of intrathecal linezolid. This report has no specific funding sources.